Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ.
Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ.
复制标题
原位灌注大鼠胰腺中生长抑素对胰高血糖素和胰岛素分泌的抑制作用。
DOI:
10.1210/endo-96-2-370
复制
发表时间:
1975
期刊:
影响因子:
4.8
通讯作者:
C. J. Goodner
中科院分区:
文献类型:
--
作者:
D. Johnson;J. Ensinck;D. Koerker;J. Palmer;C. J. Goodner
Perfusion of growth hormone inhibitory factor (somatostatin) into rat pancreas inhibited secretion of glucagon and insulin into medium containing 5.5 mM glucose. A 15-min infusion of arginine (20 mM) greatly increased glucagon and insulin secretion. When perfused simultaneously with arginine, somatostatin (55 nM) abolished the increase in glucagon secretion. The acute phase of insulin secretion in response to arginine was attenuated by somatostatin, and subsequent secretion was decreased to control levels. Pretreatment for 5 min with somatostatin blocked even acute-phase insulin secretion in response to arginine. Somatostatin did not affect basal or glucose-stimulated secretion of insulin from rat pancreatic islets isolated by the collagenase technique. Arginine-stimulated secretion of insulin was enhanced by somatostatin in isolated islets. These results demonstrate a direct effect of somatostatin on the pancreas to inhibit secretion of glucagon and insulin. The failure of somatostatin to inhibit insulin secretion in pancreatic islets may be due to alterations in the beta cells produced by the isolation procedure. It is also possible that the effect of somatostatin on insulin secretion may be mediated indirectly.